Compare RGEN & FN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | RGEN | FN |
|---|---|---|
| Founded | 1981 | 1999 |
| Country | United States | Cayman Islands |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Telecommunications Equipment |
| Sector | Health Care | Utilities |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.2B | 16.2B |
| IPO Year | N/A | 2010 |
| Metric | RGEN | FN |
|---|---|---|
| Price | $166.71 | $487.49 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 10 | 8 |
| Target Price | $174.90 | ★ $446.14 |
| AVG Volume (30 Days) | ★ 682.8K | 585.8K |
| Earning Date | 10-28-2025 | 02-02-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 14.80 |
| EPS | 0.03 | ★ 9.70 |
| Revenue | $707,890,000.00 | ★ $3,593,227,000.00 |
| Revenue This Year | $17.84 | $30.96 |
| Revenue Next Year | $12.44 | $17.15 |
| P/E Ratio | $6,507.11 | ★ $49.85 |
| Revenue Growth | 11.74 | ★ 19.71 |
| 52 Week Low | $102.97 | $148.55 |
| 52 Week High | $182.52 | $531.22 |
| Indicator | RGEN | FN |
|---|---|---|
| Relative Strength Index (RSI) | 59.62 | 56.81 |
| Support Level | $156.01 | $424.44 |
| Resistance Level | $167.74 | $531.22 |
| Average True Range (ATR) | 4.65 | 25.18 |
| MACD | -0.19 | -1.28 |
| Stochastic Oscillator | 92.75 | 57.74 |
Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category and was 58% of 2024 revenue, while chromatography, proteins, and process analytics were 19%, 12%, and 9%, respectively. Customers in North America, Europe, and Asia Pacific contributed 44%, 37%, and 19% of revenue, respectively.
Fabrinet provides advance-level optical packaging and precision optical, electro-mechanical, and electronic manufacturing services to original equipment manufacturers of complex products, such as optical communication components, modules and sub-systems, industrial lasers, automotive components, medical devices, and sensors. The company offers a broad range of advance optical and electro-mechanical capabilities across the entire manufacturing process, including process design and engineering, supply chain management, manufacturing, complex printed circuit board assembly, advance-level of packaging, integration, final assembly, and testing. The company generates the majority of its revenue from North America and Asia-Pacific, with the rest from Europe.